Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: FDA's Approval of Lerochol
In today’s Pharmaceutical Executive Daily, the FDA approves a new LDL-lowering therapy, Sanofi announces two strategic deals spanning Alzheimer’s dis…
6 months, 3 weeks ago
Pharmaceutical Executive Daily: TrumpRx's Critical Blind Spot
In today’s Pharmaceutical Executive Daily, new analysis highlights access gaps in the TrumpRx framework, the FDA awards a national priority voucher t…
6 months, 3 weeks ago
Pharmaceutical Executive Daily: Retatrutide's Positive Phase III Trial Results
In today’s Pharmaceutical Executive Daily, Eli Lilly reports positive topline Phase III results for retatrutide, the FDA expands Amgen’s Uplizna labe…
6 months, 4 weeks ago
Pharmaceutical Executive Daily: FDA's Approval of Waskyra
In today’s Pharmaceutical Executive Daily, new analysis outlines what it may truly cost to fix the biopharma ecosystem, the FDA approves Waskyra for …
7 months ago
Pharmaceutical Executive Daily: FDA's New Standard for CAR-T Approvals
In today’s Pharmaceutical Executive Daily, the FDA introduces a new superiority standard for future CAR-T approvals, Relation Therapeutics and Novart…
7 months ago
Pharmaceutical Executive Daily: Carvykti Demonstrates Sustained Remissions
In today’s Pharmaceutical Executive Daily, new analysis outlines how EMA support programs help lower drug market entry costs, early real-world data s…
7 months ago
Pharmaceutical Executive Daily: FDA Approves Breyanzi
In today’s Pharmaceutical Executive Daily, the FDA greenlights an expanded use of Breyanzi, Eli Lilly reports Jaypirca met its primary endpoint in a …
7 months ago
Pharmaceutical Executive Daily: Mark Cuban's Push for Generic Drug Fee Waivers
In today’s Pharmaceutical Executive Daily, former FDA commissioners caution that new vaccine policies could weaken long-established regulatory standa…
7 months, 1 week ago
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
In today’s Pharmaceutical Executive Daily, the FDA appoints Tracy Beth Høeg as acting CDER director, health systems explore new commercialization pa…
7 months, 1 week ago
Pharmaceutical Executive Daily: FDA's Agentic AI Deployment
In today’s Pharmaceutical Executive Daily, Regeneron launches a $150 million gene editing collaboration with Tessera Therapeutics, the FDA begins age…
7 months, 1 week ago